Know Cancer

or
forgot password

Survey and Follow-up of the Treatment Adherence and Medication Habits of Early Breast Cancer Patients on Adjuvant Hormonal Therapy With the Aromatase Inhibitor Arimidex


N/A
N/A
N/A
Not Enrolling
Female
Breast Cancer

Thank you

Trial Information

Survey and Follow-up of the Treatment Adherence and Medication Habits of Early Breast Cancer Patients on Adjuvant Hormonal Therapy With the Aromatase Inhibitor Arimidex


Inclusion Criteria:



- Early breast cancer

- Post menopausal

- Adjuvant hormonal Arimidex therapy

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Percent of patients remaining adherent to therapy with Arimidex

Outcome Time Frame:

Every 3 months

Safety Issue:

No

Principal Investigator

Zsolt Horvath, M.D., Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Hungarian National Institute of Oncology

Authority:

Hungary: National Institute of Pharmacy

Study ID:

NIS-OHU-ARI-2010/1

NCT ID:

NCT01081509

Start Date:

March 2010

Completion Date:

October 2011

Related Keywords:

  • Breast Cancer
  • adherence
  • early breast cancer
  • Arimidex
  • Therapy adherence
  • Breast Neoplasms

Name

Location